Publications

Bruce Jacobs

Jacobs BL, Rogers D, Yabes JG, Bandari J, Ayyash OM, Maganty A, Armann KM, Worku HA, Pace NM, Shah A, Pekala KR, Yu M, Chelly JE, Macleod LC, Davies BJ. Large reduction in opioid prescribing by a multipronged behavioral intervention after major urologic surgery. Cancer. 2020 Oct 1; doi: 10.1002/cncr.33200. PubMed PMID: 33002197.
Maganty A, Sabik LM, Sun Z, Eom KY, Li J, Davies BJ, Jacobs BL. Under Treatment of Prostate Cancer in Rural Locations. J Urol. 2020 Jan;203(1):108-114. doi: 10.1097/JU.0000000000000500. PubMed PMID: 31430233; PMCID: PMC7098431.
Jacobs BL, Yabes JG, Lopa SH, Heron DE, Chang CH, Bekelman JE, Nelson JB, Bynum JPW, Barnato AE, Kahn JM. The Influence of Stereotactic Body Radiation Therapy Adoption on Prostate Cancer Treatment Patterns. J Urol. 2020 Jan;203(1):128-136. doi: 10.1097/JU.0000000000000471. PubMed PMID: 31361571.
Li F, Pascal LE, Stolz DB, Wang K, Zhou Y, Chen W, Xu Y, Chen Y, Dhir R, Parwani AV, Nelson JB, DeFranco DB, Yoshimura N, Balasubramani GK, Gingrich JR, Maranchie JK, Jacobs BL, Davies BJ, Hrebinko RL, Bigley JD, McBride D, Guo P, He D, Wang Z. E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer. Prostate. 2019 Aug;79(11):1226-1237. doi: 10.1002/pros.23806. PubMed PMID: 31212363; PMCID: PMC6599563.
Jacobs BL, Lopa SH, Yabes JG, Nelson JB, Barnato AE, Degenholtz HB. Change in Functional Status After Prostate Cancer Treatment Among Medicare Advantage Beneficiaries. Urology. 2019 Sep;131104-111. doi: 10.1016/j.urology.2019.05.029. PubMed PMID: 31181274.
Macleod LC, Yabes JG, Yu M, Fam MM, Hale NE, Turner RM 2nd, Lopa SH, Gingrich JR, Borza T, Skolarus TA, Davies BJ, Jacobs BL. Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer. Urol Oncol. 2019 Jul;37(7):462-469. doi: 10.1016/j.urolonc.2019.04.006. PubMed PMID: 31053530.
Maganty A, Turner RM 2nd, Yabes JG, Davies BJ, Heron DE, Jacobs BL. Downstream Studies Following the Use of Bone Scan in the Staging of Muscle-invasive Bladder Cancer. Urology. 2019 Jul;12974-78. doi: 10.1016/j.urology.2019.04.009. PubMed PMID: 31005656.
Morgan TN, Turner RM II, Baptiste J, Lyon TD, Maranchie JK, Hrebinko RL, Davies BJ, Gingrich JR, Jacobs BL. Small cell bladder cancer: should we consider prophylactic cranial irradiation? Int Braz J Urol. 2019 Mar-Apr;45(2):299-305. doi: 10.1590/S1677-5538.IBJU.2018.0242. PubMed PMID: 30521161; PMCID: PMC6541124.
Hugar LA, Yabes JG, Turner RM 2nd, Fam MM, Appleman LJ, Davies BJ, Jacobs BL. Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries With Bladder Cancer: A SEER-Medicare Analysis. Urology. 2019 Feb;124191-197. doi: 10.1016/j.urology.2018.11.001. PubMed PMID: 30423302.

<< Investigators Search

Top